Checking lymph node surgery impact in men having prostate removal
Part of Cancer, Kidney & urinary clinical trials.
This study looks at whether removing lymph nodes during prostate removal helps predict outcomes in men whose scans do not show spread. It may help improve how doctors decide who benefits from lymph node surgery based on your risk level and scan results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 or older
- Your prostate cancer risk estimate for lymph node spread is 5% to 20% (Briganti risk score)
- Your PSMA PET/CT scan does not show metastases (no visible spread)
- Your planned standard treatment includes radical prostatectomy (often robot-assisted or laparoscopic)
- You must be able to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special prostate scan called PSMA PET/CT can help doctors decide which pelvic lymph nodes to remove during prostate surgery. It may improve who needs lymph node surgery by using scan results to guide the operation.
This trial compares two surgical approaches for removing lymph nodes during prostate cancer surgery in men with high-risk disease on one side of the prostate. The goal is to determine whether removing lymph nodes from both sides or just one side provides better outcomes.
This trial is testing whether a special scan (PSMA PET/CT) before surgery can help doctors decide if you need to remove lymph nodes. It is for men with high-risk prostate cancer who are already planning to have robot-assisted prostate removal.
This trial studies whether operating on a small, one-sided (unilateral) area of prostate cancer spread in the pelvic lymph nodes—found on a PSMA PET scan—can help control recurrence. It’s meant for people whose PSA is still low and whose spread appears limited on the scan.
This trial tests a surgery to remove lymph nodes in the pelvis that still show cancer after your initial prostate cancer treatment. By taking them out, it may help control the cancer and delay the need for stronger treatments.
This study tests two different radiation approaches for men with prostate cancer that has returned after surgery and is found only in the pelvic lymph nodes. The goal is to see if one schedule is better at controlling the disease while limiting side effects.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.